Have you heard of Jeuveau? If you don’t read many fashion magazines, you are probably completely unaware of this new addition to the neurotoxin injectables scene. This product was developed by Evolus and was just approved by the FDA in February 2019. Before you schedule your next Botox appointment, consider these advantages to getting these injections instead.
There is actually very little differentiation between formulas when looking at both Jeuveau and Botox. In fact, they are almost exactly identical. The difference lies in how the injectable has been categorized, patented, and licensed.
You see, Botox is used for a lot of different medical conditions that have nothing to do with cosmetic benefits, such as:
Because Botox is used for medical purposes, the FDA applies different regulations, some of which affect price. It is not marketed, patented, studied, or categorized in the same way as Botox. It is licensed only as a cosmetic treatment. That means it doesn’t have to follow as many regulations and procedures or regulations of the same type.
Botox has other competitors, namely Xeomin and Dysport. These competitors did not take the same approach as Jeuveau. Because it is patented and regulated as a cosmetic treatment only, there wasn’t as much of an investment to get it on the market. That fact combined with shortened production time allows the company to sell their anti-aging product at a much lower cost.
Contact us today to make an appointment for a consultation, so we can discuss if you are a good candidate for Jeuveau.